Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Revenue projections:

Revenue projections for TORNTPHARM
Revenue projections for TORNTPHARM

Investors may be wary of TORNTPHARM as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.

Financial Ratios:

currentRatio 1.396000
forwardPE 41.999935
debtToEquity 33.400000
earningsGrowth 0.305000
revenueGrowth 0.143000
grossMargins 0.756870
operatingMargins 0.266200
trailingEps 63.290000
forwardEps 0.000000

TORNTPHARM's current ratio being 1.396 suggests that the company has no issue servicing its short-term debt. Its strong liquidity position, supported by sufficient cash reserves and current assets, ensures that TORNTPHARM can meet its financial obligations with ease.
Torrent Pharmaceuticals Limited's positive earnings and revenue growth signal that the company is expected to expand its business. This healthy financial trend reflects an optimistic outlook, suggesting continued growth in both sales and profits for Torrent Pharmaceuticals Limited.
Positive gross and operating margins for Torrent Pharmaceuticals Limited highlight the company's profitability. These metrics reflect Torrent Pharmaceuticals Limited's efficiency in controlling costs while generating strong revenue from its core operations, signaling robust financial health.

Price projections:

Price projections for TORNTPHARM
Price projections for TORNTPHARM

The steady upward revision of Torrent Pharmaceuticals Limited's price projections indicates growing confidence in the company's performance. Analysts are becoming increasingly optimistic about Torrent Pharmaceuticals Limited's future prospects and potential for growth.

Insider Transactions:

Insider Transactions for TORNTPHARM
Insider Transactions for TORNTPHARM


Torrent Pharmaceuticals Limited had 1 buy transactions, with market price at 3224.449951171875 per share.No buy transactions took place in the period under consideration.The higher volume of sells at TORNTPHARM's current price levels could indicate potential for further price drops. If this selling trend continues, investors might expect the stock's value to decline as more shareholders exit their positions.

Recommendation changes over time:

Recommendations trend for TORNTPHARM
Recommendations trend for TORNTPHARM


A recent buy bias from analysts toward TORNTPHARM may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that TORNTPHARM might be an appealing option for those looking to grow their wealth through stock market investments.